^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
DRUG:

tovetumab (MEDI-575)

i
Other names: Anti-PDGFRa mAb, MEDI-575
Associations
Trials
Company:
AstraZeneca
Drug class:
PDGFR α inhibitor
Associations
Trials